Results 131 to 140 of about 4,867,269 (191)

Budd-Chiari Syndrome as the Presenting Feature of Systemic Immunoglobulin Light Chain Amyloidosis. [PDF]

Eur J Case Rep Intern Med
Miranda JL, Salvado C, Carmo F, Guedes A, Moreira A, Guimarães Costa T, Silva L.   +6 more
europepmc   +1 more source

Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosis. [PDF]

Haematologica
Rauf MU, Law S, Santostefano M, Hawkins PN, Petrie A, Cappelli F, Perfetto F, Razvi Y, Porcari A, Ravichandran S, Ioannou A, Bomsztyk J, Argirò A, Gaudio C, Antonioli E, Barilaro A, Delsante M, Di Maso V, Chiappini MG, Ogunbiyi O, Cohen OC, Martinez-Naharro A, Whelan C, Lachmann HJ, Wechalekar AD, Alberici F, Fontana M, Allinovi M, Gillmore JD.   +28 more
europepmc   +1 more source

Impact of the Addition of Daratumumab to the Frontline Treatment of Patients with Immunoglobulin Light-Chain Amyloidosis: A Single-Centre Experience. [PDF]

Cancers (Basel)
Alejo E, Agulló C, Puertas B, Eiros R, Rey-Búa B, Barnés C, Rodríguez-González M, López-Corral L, Santos-Briz Á, Escalante F, Pérez-García ML, Jiménez-Cabrera S, Gutiérrez NC, Puig N, Mateos MV, González-Calle V.   +15 more
europepmc   +1 more source

A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrils. [PDF]

Nat Commun
Martinez-Rivas G, Ayala MV, Bender S, Codo GR, Swiderska WK, Lampis A, Pedroza L, Merdanovic M, Sicard P, Pinault E, Richard L, Lavatelli F, Giorgetti S, Canetti D, Rinsant A, Kaaki S, Ory C, Oblet C, Pollet J, Naser E, Carpinteiro A, Roussel M, Javaugue V, Jaccard A, Bonaud A, Delpy L, Ehrmann M, Bridoux F, Sirac C.   +28 more
europepmc   +1 more source

The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis. [PDF]

Amyloid, 2020
Angel-Korman A, Jaberi A, Sanchorawala V, Havasi A.   +3 more
europepmc   +1 more source

The clinical trials landscape in immunoglobulin light chain amyloidosis: a systematic review. [PDF]

Blood Adv
Ramachandran R, Shah D, Luo C, Shah V, Cliff ERS, Sanchorawala V, Lentzsch S, Chakraborty R.   +7 more
europepmc   +1 more source

Venetoclax Plus CyBorD Induction Therapy and Venetoclax Maintenance Treatment for Immunoglobulin Light Chain Amyloidosis with t(11;14) Translocation. [PDF]

Curr Oncol
Garami G, Obajed Al-Ali O, Virga I, Gulyás A, Bedekovics J, Tornai I, Illés Á, Magyari F.   +7 more
europepmc   +1 more source

Intraoral hemorrhagic bullae as the first sign of immunoglobulin light chain amyloidosis. [PDF]

CMAJ
Dominguez-Lopez RM, Naharro-Rodriguez J.
europepmc   +1 more source

Coexistence of variant-type transthyretin and immunoglobulin light-chain amyloidosis: a case report. [PDF]

Eur Heart J Case Rep
Eda Y, Ishii S, Onagi S, Katoh N, Ako J.
europepmc   +1 more source

Prognostic factors in Chinese patients with immunoglobulin light chain amyloidosis: a scoping review and meta-analysis. [PDF]

Ann Med
Wu Y, Wang X, Gào X, Xu L, Wang B, Cai Z.   +5 more
europepmc   +1 more source